![Kimihiko Fujisawa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kimihiko Fujisawa
Gründer bei Aqumen Biopharmaceuticals KK
Aktive Positionen von Kimihiko Fujisawa
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aqumen Biopharmaceuticals KK
![]() Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Direktor/Vorstandsmitglied | 06.08.2009 | - |
Gründer | 04.05.2010 | - |
Karriereverlauf von Kimihiko Fujisawa
Ausbildung von Kimihiko Fujisawa
Kyushu University | Doctorate Degree |
Statistik
International
Japan | 3 |
Operativ
Director/Board Member | 1 |
Founder | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Aqumen Biopharmaceuticals KK
![]() Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Health Technology |
- Börse
- Insiders
- Kimihiko Fujisawa
- Erfahrung